InflaRx (IFRX) has received EU regulatory approval for its treatment Gohibic for the treatment of COVID-19 patients ...

Dr. Grant Colfax, the San Francisco's public health director who oversaw the city's responses to the COVID-19 pandemic and ...

The European Commission granted an approval under exceptional circumstances to InflaRx’s immunosuppressant. The European ...

An attorney for Keith Middlebrook said they would appeal and called Magic Johnson, who testified during trial, "the biggest ...

Between a third and a half of the populations of the four UK nations had not had the recommended number of COVID vaccinations and boosters by summer 2022, according to the first research study to look ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

When virologists took their first peek at XEC, the Covid-19 variant which started to become dominant in the autumn of 2024, ...

The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant ...

The landscape of pandemic response has been transformed, with new standards being set for clinical excellence. A new report looks at emerging therapies, trial insights, and the innovations shaping the ...

Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...